back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-12-11 12:53 Tx date 2025-12-10 |
$QNTM
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Holder: Xorax Family Trust (Indirect Ownership)
|
Multiple Voting Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$375.00
+15 vol $25.00 each |
21 | |
| Filed 2025-12-11 12:51 Tx date 2025-12-10 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Fortius Research and Trading Corp. (Indirect Ownership)
|
Multiple Voting Shares Class A
16 - Acquisition or disposition under a prospectus exemption
|
$375.00
+15 vol $25.00 each |
21 | |
| Filed 2025-11-26 16:55 Tx date 2025-11-26 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-6,655
-500 vol $13.31 each |
0 | |
| Filed 2025-11-26 16:54 Tx date 2025-11-26 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-68,415.94
-6,967 vol $9.82 each |
500 | |
| Filed 2025-11-26 16:54 Tx date 2025-11-25 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-94,220
-14,000 vol $6.73 each |
7,467 | |
| Filed 2025-11-26 16:53 Tx date 2025-11-24 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-81,250
-13,000 vol $6.25 each |
21,467 | |
| Filed 2025-11-21 16:22 Tx date 2025-11-21 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-46,880
-8,000 vol $5.86 each |
34,467 | |
| Filed 2025-11-21 16:22 Tx date 2025-11-20 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-100,480
-16,000 vol $6.28 each |
42,467 | |
| Filed 2025-11-21 16:21 Tx date 2025-11-18 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-134,480.85
-21,245 vol $6.33 each |
58,467 | |
| Filed 2025-11-21 16:21 Tx date 2025-11-18 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-41,358
-6,100 vol $6.78 each |
79,712 | |
| Filed 2025-11-21 16:20 Tx date 2025-11-17 |
$QNTM
Quantum BioPharma Ltd. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
10 - Acquisition or disposition in the public market
|
$-39,423
-5,100 vol $7.73 each |
85,812 | |
| Filed 2025-10-29 22:06 Tx date 2025-10-29 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Jacqueline Burns (Indirect Ownership)
|
Subordinate Voting Shares Class B
90 - Change in the nature of ownership
|
-647 vol |
0 | |
| Filed 2025-10-29 22:05 Tx date 2025-10-29 |
$QNTM
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
11 - Acquisition or disposition carried out privately
|
-77,000 vol |
29,114 | |
| Filed 2025-10-01 11:21 Tx date 2025-09-26 |
$QNTM
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
7,000 | |
| Filed 2025-09-30 15:35 Tx date 2025-09-26 |
$QNTM
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
7,000 | |
| Filed 2025-09-30 15:34 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 15:31 Tx date 2025-09-26 |
$QNTM
Quantum BioPharma Ltd. |
Bashir, Muhammad Adnan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
7,000 | |
| Filed 2025-09-30 15:31 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Bashir, Muhammad Adnan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
||
| Filed 2025-09-30 15:30 Tx date 2025-09-26 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
14,692 | |
| Filed 2025-09-30 15:29 Tx date 2025-09-24 |
$QNTM
Quantum BioPharma Ltd. |
Zapolin, Michael Shawn
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |